197 related articles for article (PubMed ID: 25704592)
1. Sympathetic nervous system activation and β-adrenoceptor blockade in right heart failure.
Andersen S; Andersen A; de Man FS; Nielsen-Kudsk JE
Eur J Heart Fail; 2015 Apr; 17(4):358-66. PubMed ID: 25704592
[TBL] [Abstract][Full Text] [Related]
2. Use of β-Blockers in Pulmonary Hypertension.
Perros F; de Man FS; Bogaard HJ; Antigny F; Simonneau G; Bonnet S; Provencher S; Galiè N; Humbert M
Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364092
[TBL] [Abstract][Full Text] [Related]
3. Rationale for treatment of patients with chronic heart failure with adrenergic blockade.
Sackner-Bernstein JD; Mancini DM
JAMA; 1995 Nov; 274(18):1462-7. PubMed ID: 7474194
[TBL] [Abstract][Full Text] [Related]
4. The human sympathetic nervous system: its relevance in hypertension and heart failure.
Parati G; Esler M
Eur Heart J; 2012 May; 33(9):1058-66. PubMed ID: 22507981
[TBL] [Abstract][Full Text] [Related]
5. The use of beta-blockade therapy in treatment of congestive heart failure.
Sobotka PA; Gunnar RM
Clin Cardiol; 1992 Sep; 15(9):630-5. PubMed ID: 1356677
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of the central nervous system beta-adrenoceptor blockade on the failing heart.
Gourine A; Bondar SI; Spyer KM; Gourine AV
Circ Res; 2008 Mar; 102(6):633-6. PubMed ID: 18323523
[TBL] [Abstract][Full Text] [Related]
7. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
Packer M
J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
[TBL] [Abstract][Full Text] [Related]
8. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of heart failure with beta-blockers?].
Osterziel KJ; Dietz R
Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
[TBL] [Abstract][Full Text] [Related]
10. [Beta-adrenoceptor antagonists in the treatment of chronic heart failure].
Bundkirchen A; Brixius K; Schwinger RH
Pharmazie; 2004 Feb; 59(2):83-92. PubMed ID: 15025174
[TBL] [Abstract][Full Text] [Related]
11. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system.
Packer M
Postgrad Med; 1988 Feb; Spec No():96-103. PubMed ID: 2894667
[TBL] [Abstract][Full Text] [Related]
12. Potential use of beta(3)-adrenoceptor antagonists in heart failure therapy.
Moniotte S; Balligand JL
Cardiovasc Drug Rev; 2002; 20(1):19-26. PubMed ID: 12070531
[TBL] [Abstract][Full Text] [Related]
13. The neuroendocrine and sympathetic nervous system in congestive heart failure.
Ferrari R; Ceconi C; Curello S; Visioli O
Eur Heart J; 1998 Jun; 19 Suppl F():F45-51. PubMed ID: 9651735
[TBL] [Abstract][Full Text] [Related]
14. Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure.
Ameri P; Bertero E; Meliota G; Cheli M; Canepa M; Brunelli C; Balbi M
Heart Fail Rev; 2016 Sep; 21(5):539-47. PubMed ID: 27206576
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of the Sympathetic Nervous System in the Development and Progression of Pulmonary Arterial Hypertension.
Liu RX; Luo Q; Qiao H; Yu J; Zhang QL; Wang P; Cao YG; Jiang CL; Qu LH
Curr Neurovasc Res; 2017; 14(2):190-198. PubMed ID: 28088894
[TBL] [Abstract][Full Text] [Related]
16. The sympathetic nervous system in chronic heart failure.
Joseph J; Gilbert EM
Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):9-16. PubMed ID: 9715818
[TBL] [Abstract][Full Text] [Related]
17. The sympathetic nervous system and pathophysiology of congestive heart failure.
Farmer J
Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):6-11. PubMed ID: 19667705
[TBL] [Abstract][Full Text] [Related]
18. The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation.
Bassiakou E; Xanthos T; Papadimitriou L
Eur J Pharmacol; 2009 Aug; 616(1-3):1-6. PubMed ID: 19555681
[TBL] [Abstract][Full Text] [Related]
19. Beta blocker treatment in heart failure.
Carson PE
Prog Cardiovasc Dis; 1999; 41(4):301-21. PubMed ID: 10362350
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockers in pulmonary arterial hypertension: Time for a second thought?
Badagliacca R; Mercurio V; Romeo E; Correale M; Masarone D; Papa S; Tocchetti CG; Agostoni P;
Vascul Pharmacol; 2022 Jun; 144():106974. PubMed ID: 35248781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
